{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:54:17Z","timestamp":1791348857584,"version":"4.3.1"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T00:00:00Z","timestamp":1439942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135873","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T18:03:11Z","timestamp":1440007391000},"page":"e0135873","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases"],"prefix":"10.1371","volume":"10","author":[{"given":"Marta","family":"G\u00f3mez-Grau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Cozar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Rodriguez-Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bru","family":"Cormand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00efsa","family":"Vilageliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","article-title":"Lysosomal storage diseases\u2014the horizon expands","volume":"9","author":"RM Boustany","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2012.07.007","article-title":"Pharmaceutical therapies to recode nonsense mutations in inherited diseases","volume":"136","author":"HL Lee","year":"2012","journal-title":"Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","article-title":"Therapeutics based on stop codon readthrough","volume":"15","author":"KM Keeling","year":"2014","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref4","first-page":"3421","article-title":"The metabolic and molecular bases of inherited disease","volume":"3","author":"EF Neufeld","year":"2001"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/508068","article-title":"Identification of the gene encoding the enzyme deficient in mucopolysaccharidosis IIIC (Sanfilippo disease type C)","volume":"79","author":"X Fan","year":"2006","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/508294","article-title":"Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome)","volume":"79","author":"M Hrebicek","year":"2006","journal-title":"Am J Hum Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1073\/pnas.75.10.5185","article-title":"Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts","volume":"75","author":"U Klein","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","first-page":"3589","article-title":"The metabolic and molecular bases of inherited disease","volume":"3","author":"EH Schuchman","year":"2001"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2012.06467.x","article-title":"SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic models","volume":"1250","author":"RA Gatti","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nm0496-467","article-title":"Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations","volume":"2","author":"M Howard","year":"1996","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"ER Barton-Davis","year":"1999","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.bmc.2010.03.060","article-title":"Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations","volume":"18","author":"I Nudelman","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.molmed.2012.09.008","article-title":"Sense from nonsense: therapies for premature stop codon diseases","volume":"18","author":"L Bidou","year":"2012","journal-title":"Trends Mol Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/hmg\/10.3.291","article-title":"Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation","volume":"10","author":"KM Keeling","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jmb.2004.03.012","article-title":"alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients","volume":"338","author":"LK Hein","year":"2004","journal-title":"J Mol Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molmed.2006.06.001","article-title":"Stop-codon read-through for patients affected by a lysosomal storage disorder","volume":"12","author":"DA Brooks","year":"2006","journal-title":"Trends Mol Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2011.10.005","article-title":"The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse","volume":"105","author":"D Wang","year":"2012","journal-title":"Mol Genet Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10545-012-9521-y","article-title":"Pharmacological read-through of nonsense ARSB mutations as a potential therapeutic approach for mucopolysaccharidosis VI","volume":"36","author":"R Bartolomeo","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ymgme.2013.12.007","article-title":"Long-term nonsense suppression therapy moderates MPS I-H disease progression","volume":"111","author":"G Gunn","year":"2014","journal-title":"Mol Genet Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00109-006-0045-5","article-title":"Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model","volume":"84","author":"M Du","year":"2006","journal-title":"J Mol Med (Berl)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00439-006-0245-7","article-title":"Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts","volume":"120","author":"VB Mattis","year":"2006","journal-title":"Hum Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2009.04.004","article-title":"Stop codon read-through of a methylmalonic aciduria mutation","volume":"97","author":"NE Buck","year":"2009","journal-title":"Mol Genet Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1084\/jem.20081940","article-title":"Nonaminoglycoside compounds induce readthrough of nonsense mutations","volume":"206","author":"L Du","year":"2009","journal-title":"J Exp Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1016\/j.bmcl.2011.07.107","article-title":"Synthesis and evaluation of compounds that induce readthrough of premature termination codons","volume":"21","author":"ME Jung","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","article-title":"Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations","volume":"52","author":"I Nudelman","year":"2009","journal-title":"J Med Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"EM Welch","year":"2007","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1073\/pnas.0711795105","article-title":"PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model","volume":"105","author":"M Du","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0883073810371129","article-title":"Read-through strategies for suppression of nonsense mutations in Duchenne\/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124)","volume":"25","author":"RS Finkel","year":"2010","journal-title":"J Child Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/hum.2010.067","article-title":"PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C","volume":"22","author":"T Goldmann","year":"2011","journal-title":"Hum Gene Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10545-010-9265-5","article-title":"PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation","volume":"34","author":"L Tan","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/jcb.22979","article-title":"Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations","volume":"112","author":"PK Dranchak","year":"2011","journal-title":"J Cell Biochem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/humu.22047","article-title":"Feasibility of nonsense mutation readthrough as a novel therapeutical approach in propionic acidemia","volume":"33","author":"R Sanchez-Alcudia","year":"2012","journal-title":"Hum Mutat"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e1001593","DOI":"10.1371\/journal.pbio.1001593","article-title":"A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays","volume":"11","author":"SP McElroy","year":"2013","journal-title":"PLoS Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-med-120611-144851","article-title":"Ataluren as an agent for therapeutic nonsense suppression","volume":"64","author":"SW Peltz","year":"2013","journal-title":"Annu Rev Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI70462","article-title":"Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects","volume":"124","author":"CY Gregory-Evans","year":"2014","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy","volume":"48","author":"MT Howard","year":"2000","journal-title":"Ann Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"M Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.gt.3302211","article-title":"Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment","volume":"11","author":"L Bidou","year":"2004","journal-title":"Gene Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jgm.1140","article-title":"Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes","volume":"10","author":"V Allamand","year":"2008","journal-title":"J Gene Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ejhg.2009.122","article-title":"In vitro readthrough of termination codons by gentamycin in the Stuve-Wiedemann Syndrome","volume":"18","author":"S Bellais","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ymgme.2007.06.002","article-title":"Identification of the molecular defects in Spanish and Argentinian mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) patients, including 9 novel mutations","volume":"92","author":"E Garrido","year":"2007","journal-title":"Mol Genet Metab"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1005627311402","article-title":"Allelic heterogeneity in Spanish patients with Sanfilippo disease type B. Identification of eight new mutations","volume":"24","author":"MJ Coll","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10545-013-9668-1","article-title":"Treatment effect of coenzyme Q and an antioxidant cocktail in fibroblasts of patients with Sanfilippo disease","volume":"37","author":"L Matalonga","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"ref44","first-page":"837","article-title":"Identification of mutations in the arylsulfatase B gene in Russian mucopolysaccharidosis type VI patients","volume":"36","author":"E Voskoboeva","year":"2000","journal-title":"Genetika"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0925-4439(98)00099-4","article-title":"Maroteaux-lamy syndrome: five novel mutations and their structural localization","volume":"1453","author":"GR Villani","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/humu.21018","article-title":"Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients","volume":"30","author":"L Rodriguez-Pascau","year":"2009","journal-title":"Hum Mutat"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/humu.1380060412","article-title":"Two new mutations in the acid sphingomyelinase gene causing type a Niemann-pick disease: N389T and R441X","volume":"6","author":"EH Schuchman","year":"1995","journal-title":"Hum Mutat"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2007.09.011","article-title":"Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands","volume":"93","author":"GJ Ruijter","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.cca.2011.08.032","article-title":"Molecular characterization of MPS IIIA, MPS IIIB and MPS IIIC in Tunisian patients","volume":"412","author":"S Ouesleti","year":"2011","journal-title":"Clin Chim Acta"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13023-014-0180-y","article-title":"Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations","volume":"9","author":"L Matos","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ymgme.2008.02.012","article-title":"Maroteaux-Lamy syndrome: functional characterization of pathogenic mutations and polymorphisms in the arylsulfatase B gene","volume":"94","author":"E Garrido","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/mt.2013.150","article-title":"A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM gene","volume":"21","author":"L Du","year":"2013","journal-title":"Mol Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"19483","DOI":"10.1073\/pnas.1312088110","article-title":"Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons","volume":"110","author":"C Kuschal","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","first-page":"1","article-title":"Using the Student t-test with extremely small sample sizes","volume":"18","author":"JCF de Winter","year":"2013","journal-title":"Prac Assess Res Eval"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molmed.2012.09.004","article-title":"Cancer syndromes and therapy by stop-codon readthrough","volume":"18","author":"R Bordeira-Carrico","year":"2012","journal-title":"Trends Mol Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"15676","DOI":"10.1073\/pnas.0405155101","article-title":"Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons","volume":"101","author":"CH Lai","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/nar\/gkq1277","article-title":"Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides","volume":"39","author":"C Floquet","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1093\/hmg\/dds223","article-title":"Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy","volume":"21","author":"R Kayali","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"e1002608","DOI":"10.1371\/journal.pgen.1002608","article-title":"Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin","volume":"8","author":"C Floquet","year":"2012","journal-title":"PLoS Genet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:56:52Z","timestamp":1589039812000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135873"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Dardis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,19]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135873","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,19]]}}}